President Donald Trump says Regeneron has agreed to offer prescription drugs at most-favored-nation prices. The agreement marks a shift in pharmaceutical pricing strategy for the company.
President Donald Trump announced that Regeneron has agreed to provide prescription drugs at most-favored-nation prices.
What happened
President Donald Trump announced that Regeneron has agreed to provide prescription drugs at most-favored-nation prices.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Project Prometheus, led by Jeff Bezos and Vik Bajaj, secures $10 billion in new funding. The round values the company at approximately $38 billion.
Project Prometheus, led by Jeff Bezos and Vik Bajaj, has secured $10 billion in funding, bringing the company's valuation to approximately $38 billion.
Nike announces it is cutting roughly 1,400 positions across its worldwide operations.
Nike announced it is cutting approximately 1,400 positions across its worldwide operations.
Meta announces layoffs affecting 8,000 employees, or roughly 10% of its total workforce.
Meta announced on Thursday that it is laying off approximately 8,000 employees, representing about 10% of its total workforce.
U.S. Commerce Secretary Lutnick projects $1 trillion in semiconductor manufacturing investment. The announcement highlights ongoing efforts to expand domestic chip production capacity.
U.S. Commerce Secretary Lutnick stated that the administration anticipates $1 trillion in investment for semiconductor manufacturing facilities.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.